BioSpace News Archive

Pharm Country

Latest Odronextamab Data in Relapsed/Refractory Follicular Lymphoma Showed Compelling Responses and Overall Maintenance of Patient-Reported Outcomes

Regeneron Pharmaceuticals, Inc. announced positive data for odronextamab in patients with relapsed/refractory follicular lymphoma from a pivotal Phase 2 trial.

December 10, 2023
·
13 min read
Latest Data of InnoCare’s Oncology Pipelines Presented at the 65th Annual Meeting of ASH

InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced that the latest data from InnoCare’s oncology studies were presented at the 65th American Society of Hematology Annual Meeting.

December 10, 2023
·
4 min read
Drug Development

Long-term ALPHA Phase III trial data showed danicopan as add-on to ULTOMIRIS® or SOLIRIS® sustained clinical improvements in subset of patients with PNH experiencing clinically significant extravascular hemolysis

Positive results from the 24-week and long-term extension period of the pivotal ALPHA Phase III trial showed danicopan as add-on to standard of care C5 inhibitor therapy ULTOMIRIS® or SOLIRIS® continued to demonstrate clinical benefit for patients with paroxysmal nocturnal hemoglobinuria who experience clinically significant extravascular hemolysis.

December 10, 2023
·
29 min read